Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01867346 · ClinicalTrials.gov registry record
Early Markers of Cognitive Change and Alzheimer s Disease
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 2,850
- Enrollment target
NCT01867346: Completed study, sponsored by National Institute on Aging (NIA).
NCT01867346 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 2,850 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01867346 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 2,850 participants
- Enrollment target
Study Summary
Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a long-term study of human aging. To see how the brain changes with age, researchers will study BLSA participants who are at least 60 years old. In particular, researchers are looking for early markers of possible Alzheimer's disease and other conditions that cause memory loss. To do so, they will give tests of memory and brain function, and stay in close contact with participants. Objectives: \- To study cognitive changes that occur in normal aging and in people who develop memory problems. Eligibility: \- Individuals at least 60 years of age who are participating in the BLSA. Design: * There are three parts to this study. These study procedures will be done under the usual BLSA guidelines. * Participants will take paper and pencil tests. The tests measure skills such as language, attention, memory, and problem solving. They will also ask questions about emotions and feelings. * Participants will give the name and phone number of a person who knows them well and sees them often. Researchers will ask this person to fill out questionnaires on the effects of aging on the participant. These questions will monitor the participant's memory and ability to function independently. * Participants will have regular phone calls between study visits. These calls will help to keep their information up to date. * Participants will continue on this study for as long as they are able to participate.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,850 participants |
| Start Date | 2003-03-19 |
| Est. Completion | 2015-01-02 |
What the finished NCT01867346 record still lists
NCT01867346 is an observational study that tracks outcomes without assigning an intervention. Its 2,850 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01867346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01867346 about?
NCT01867346 is a clinical study titled "Early Markers of Cognitive Change and Alzheimer s Disease". Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a long-term study of human aging. To see how the brain changes with age, researchers will study BLSA participants who are at least 60 years old. In particular, researchers are looking for early markers of possible Alzheimer's diseas...
What is the current status of trial NCT01867346?
This trial is currently completed. The enrollment target is 2,850 participants. The study started on 2003-03-19. Estimated completion is 2015-01-02.
Who is sponsoring clinical trial NCT01867346?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06150781 · 2,842 participants
Aimovig Pregnancy Exposure Registry
- NCT06351085 · 2,869 participants · NA
Enhancing Lung Cancer Screening Through Human-Centered Intervention
- NCT05624450 · 2,870 participants · Phase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- NCT02273297 · 2,821 participants
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI